First Patient Dosing achieved in Mainland China in a Phase II Multi-regional clinical trial (MRCT) Life Science
Ionis and Roche Ink Deal Worth More Than $700 Million for Dry AMD Treatment Collaboration Life Science
MEI Pharma and BeiGene Announce Clinical Collaboration to Evaluate ME-401 in Combination with Zanubrutinib in Patients with B-Cell Malignancies Life Science